Volume 1, Issue 1
Editorialp. 5
Selecting patients for osteoporosis therapy: the new WHO paradigm
Author(s): Stuart L Silverman
Editorialp. 7
Anti-inflammatory therapy and cardiovascular risk: new insights
Author(s): silvano Adami
Drug Evaluationp. 15
Abatacept: the first-in-class costimulation blocker for the treatment of rheumatoid arthritis
Author(s): Rene Westhovens
Priority Paper Evaluationp. 23
The preventative role of heparin in antiphospholipid antibody-induced fetal loss
Author(s): Ronald A Asherson
Conference Proceedingp. 27
Advances in the molecular pharmacology and therapeutics of bone disease
Author(s): T J Martin
Research Paperp. 31
Role of synoviolin in rheumatoid arthritis: possible clinical revelance
Author(s): Nakajima
Perspectivep. 37
Adherence to anti-osteoporotic treatment: does it really matter?
Author(s): Jean Yves Reginster
Review Articlep. 41
Nailfold videocapillaroscopy for the early diagnosis of systemic sclerosis in Raynaud\'s phenomenon
Author(s): Maurizio Cutolo
Review Articlep. 53
Chemokines in arthritis: key molecules in pathogenesis and potential therapeutic targets
Author(s): Costantino Pitzalis
Research Articlep. 79
Genetics and clinical characteristics to predict rheumatoid arthritis: where are we now and what are the future prospects?
Author(s): Helm-van Mil
Research Articlep. 91
Manipulation of apoptosis as a treatment modality in rheumatoid arthritis
Author(s): Maria Bokarewa
Research Articlep. 121
Computer-assisted total hip arthroplasty: the present and the future
Author(s): Mahmoud A Hafez
Research Articlep. 133
Therapeutics approaches in bone pathogeneses: targeting the IKK/NF-kB axis
Author(s): Yousef Abu-Amer
